Idiopathic basal ganglia calcification 1
|
disease |
Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
6
|
26
|
0.300 |
None |
|
0 |
|
|
|
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.270 |
None |
0.875 |
8 |
|
2005 |
2017 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.220 |
None |
1.000 |
4 |
|
1991 |
2015 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.220 |
None |
1.000 |
3 |
|
2005 |
2007 |
Myeloproliferative disease
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
365
|
43
|
0.200 |
None |
1.000 |
28 |
|
2000 |
2019 |
Eosinophilia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
325
|
23
|
0.200 |
None |
0.962 |
26 |
|
2002 |
2019 |
Primary familial brain calcification
|
disease |
Nutritional and Metabolic Diseases
|
Congenital Abnormality
|
12
|
6
|
0.200 |
None |
1.000 |
10 |
4
|
2015 |
2020 |
Chronic rejection of renal transplant
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
64
|
1
|
0.200 |
None |
1.000 |
1 |
|
2002 |
2002 |
Oligohydramnios
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
129
|
21
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Neointima
|
disease |
Pathological Conditions, Signs and Symptoms
|
Acquired Abnormality
|
40
|
|
0.200 |
None |
1.000 |
1 |
|
1997 |
1997 |
Cholestasis, Extrahepatic
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
87
|
|
0.200 |
None |
1.000 |
1 |
|
2008 |
2008 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.200 |
None |
1.000 |
1 |
|
2000 |
2000 |
Hyperoxia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
50
|
|
0.200 |
None |
1.000 |
1 |
|
2005 |
2005 |
Infarction, Middle Cerebral Artery
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
145
|
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Experimental Autoimmune Encephalomyelitis
|
disease |
Immune System Diseases; Nervous System Diseases
|
Experimental Model of Disease
|
97
|
|
0.200 |
None |
1.000 |
1 |
|
2005 |
2005 |
Sciatic Neuropathy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
115
|
|
0.200 |
None |
1.000 |
1 |
|
2009 |
2009 |
Cardiomegaly
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Finding
|
267
|
11
|
0.200 |
None |
1.000 |
1 |
|
2002 |
2002 |
Graft Rejection
|
phenotype |
|
Organ or Tissue Function
|
47
|
|
0.200 |
None |
1.000 |
1 |
|
1999 |
1999 |
Intimal proliferation
|
phenotype |
|
Pathologic Function
|
7
|
|
0.200 |
None |
1.000 |
1 |
|
2000 |
2000 |
Severe nonproliferative diabetic retinopathy
|
disease |
Eye Diseases; Endocrine System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
5
|
3
|
0.200 |
None |
|
0 |
|
|
|
MYOFIBROMATOSIS, INFANTILE, 2
|
disease |
|
Disease or Syndrome
|
2
|
7
|
0.200 |
None |
|
0 |
|
|
|
Psychotic Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
560
|
179
|
0.110 |
None |
1.000 |
1 |
|
2015 |
2015 |
Lipodystrophy
|
disease |
Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
226
|
28
|
0.110 |
None |
1.000 |
1 |
|
2019 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.986 |
69 |
1
|
1992 |
2019 |
Eosinophilic disorder
|
group |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
288
|
22
|
0.100 |
None |
0.964 |
28 |
|
2002 |
2019 |